GlassScriptPhysician profile
Nancy A Denicola
NPI 1568450690
$2,097.13
in general payments reported to CMS, 2019-2025
19 companies · $361 in 2025
The $361 reported for 2025 was more than what 88% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $168 · 2021: $284 · 2022: $390 · 2023: $365 · 2024: $401 · 2025: $361.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $436.94 | 2019-2025 | Doc Band |
| Supernus Pharmaceuticals, INC. | $300.47 | 2021-2022 | |
| Glaxosmithkline, LLC. | $193.38 | 2023-2024 | Bexsero |
| Ars Pharmaceuticals Operations, INC. | $179.95 | 2025 | Neffy |
| Sanofi Pasteur INC. | $167.87 | 2019-2024 | |
| Pfizer INC. | $141.78 | 2020-2025 | |
| Merck Sharp & Dohme LLC | $137.45 | 2022-2025 | Gardasil 9, Vaxneuvance, Rotateq |
| Kaleo, INC. | $121.69 | 2019-2024 | Auvi-Q |
| Phadia US INC. | $92.06 | 2020-2024 | Immunocap |
| Corium, LLC | $61.46 | 2022-2024 | Azstarys |
| Seqirus USA INC | $58.61 | 2022-2024 | Flucelvax |
| Noven Therapeutics, LLC | $49.32 | 2024 | Xelstrym |
| Cumberland Pharmaceuticals, INC. | $38.54 | 2022 | |
| Collegium Pharmaceutical, INC. | $31.07 | 2025 | Jornay Pm |
| Astrazeneca Pharmaceuticals LP | $29.02 | 2020-2024 | Flumist Quadrivalent |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $16.53 | 2024 | |
| Galderma Laboratories, L.P. | $14.89 | 2021 | |
| Genentech USA, INC. | $13.64 | 2021 | |
| Adlon Therapeutics L.P. | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Denicola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.